Multiple Keratoacanthomas Arising in the Setting of Sorafenib Therapy: Novel Chemoprophylaxis With Bexarotene

Cancer Control - United States
doi 10.1177/107327480901600110
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Methodology of a Novel Risk Stratification Algorithm for Patients With Multiple Myeloma in the Relapsed Setting

Oncology and Therapy
Oncology
2019English

Bexarotene – A Novel Modulator of AURKA and the Primary Cilium in VHL-deficient Cells

Journal of Cell Science
Cell Biology
2018English

Malignant Melanoma Arising in the Setting of Epidermolysis Bullosa Simplex

JAMA Dermatology
DermatologyMedicine
2013English

Transient Eruptive Keratoacanthomas Associated With Nivolumab

JAAD Case Reports
Dermatology
2019English

Ten-Year Experience of Bexarotene Therapy for Cutaneous T-Cell Lymphoma in Finland

Acta Dermato-Venereologica
DermatologyMedicine
2012English

Inhibition of Cyclin-Dependent Kinase 5 - A Novel Strategy to Improve Sorafenib Response in HCC Therapy

Hepatology
MedicineHepatology
2018English

Clinicopathological Features of Ophthalmic Neoplasms Arising in the Setting of Xeroderma Pigmentosum

Ocular Oncology and Pathology
Nursing
2015English

Value of Novel Agents and Intensive Therapy for Patients With Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
2013English

Role of the Pharmacist in Pre-Exposure Chemoprophylaxis (PrEP) Therapy for HIV Prevention

Pharmacy Practice
Pharmaceutical SciencePharmacy
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy